Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05579444 · ClinicalTrials.gov registry record
Systems Biology of Gastrointestinal and Related Diseases
A clinical trial, sponsored by Viome.
- Terminated
- Registry status
- 17
- Enrollment target
NCT05579444: Clinical Trial study, sponsored by Viome.
NCT05579444 is a clinical trial that was terminated before completion, run by Viome. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05579444 was terminated before completion, sponsored by Viome.
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This is a longitudinal observational study on patients with gastrointestinal and related disease. The study will be conducted for at least 10 years, following each participant over time, as they either go through relapses and remissions, or progression of their disease.
Primary Outcome
Identification of biomarkers that indicate gastrointestinal diseases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-11-11 |
| Est. Completion | 2023-11-29 |
Why NCT05579444 stopped before completion
NCT05579444 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05579444 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05579444 about?
NCT05579444 is a clinical study titled "Systems Biology of Gastrointestinal and Related Diseases". This is a longitudinal observational study on patients with gastrointestinal and related disease. The study will be conducted for at least 10 years, following each participant over time, as they either go through relapses and remissions, or progression of their disease.
What is the current status of trial NCT05579444?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2022-11-11. Estimated completion is 2023-11-29.
Who is sponsoring clinical trial NCT05579444?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI